PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pediatric Melatonin Linked to Small REM Sleep Reduction

melatonindietary supplementspediatric insomniasleep architectureREM sleeppolysomnographypropensity score matchingobservational studyneurologypediatrics Pediatric Pharmacy

Background Information

Melatonin may reduce REM sleep in children without affecting total sleep time.

Melatonin is commonly used as a sleep aid in children, yet its impact on sleep architecture using polysomnography (PSG) is not well understood. Outpatient melatonin use in children is associated with a small reduction in the percentage of rapid eye movement (REM) sleep but no differences in total sleep time or other sleep parameters. This study suggests melatonin use affects REM sleep without altering other sleep characteristics, but results might be influenced by residual confounding; further studies on dosage and adherence are needed. Melatonin may slightly reduce REM sleep in children without affecting overall sleep duration or quality.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Juginovic A, Rodman L

Citation: Juginovic A, Rodman L Melatonin Use and Polysomnographic Sleep Architecture in Children. JAMA network open. 2026;9(8):e2626983. doi:10.1001/jamanetworkopen.2026.26983

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.